Advertisement

Horner syndrome in ipsilateral lenticulostriate stroke: a novel localization for a classic stroke syndrome

  • Stefania Nannoni
  • Philippe Maeder
  • François Vingerhoets
  • Patrik Michel
Short Communication

Abstract

Horner’s syndrome has important localizing and etiological value in acute ischemic stroke. In a prospective series of consecutive acute ischemic stroke patients, we identified three patients with Horner’s syndrome and contralateral hemiparesis due to ipsilateral small deep infarction in the middle cerebral artery territory (lenticulostriate arteries). Lacunar stroke was the most likely stroke mechanism in all three patients. This observation might suggest the existence of an uncrossed cortico-hypothalamic sympathetic pathway passing through the basal ganglia and modulating oculosympathetic function.

Keywords

Alternate syndrome Horner syndrome Lacunar stroke Acute ischemic stroke 

Notes

Acknowledgements

We thank Dr Andrea Rossetti from the Centre Hospitalier Universitaire Vaudois for helpful discussion and suggestions for this manuscript. We thank Melanie Price Hirt for English language correction and editing.

Author Contributions

Stefania Nannoni, study concept and design, acquisition of data Philippe Maeder, analysis and interpretation of radiological data François Vingerhoets, analysis and interpretation of clinical data Patrik Michel, study concept and design, analysis and interpretation of data, study supervision and critical revision of manuscript for intellectual content.

Funding

This project was supported by the European Academy of Neurology (EAN).

Compliance with ethical standards

Conflict of interest

Stefania Nannoni reports no disclosures. Philippe Maeder reports no disclosures. François Vingerhoets reports no disclosures. Prof. Patrik Michel has received funding within the last 3 years through his institution research grants from the Swiss Heart Foundation, Boehringer-Ingelheim, and BMS; speaker fees from Boehringer-Ingelheim, Bayer, Daiichi-Sankyo, Medtronic, and Amgen; honoraria from scientific advisory boards from Boehringer-Ingelheim, Bayer, Pfizer and BMS; consulting fees from Medtronic, Astra-Zeneca, and Amgen. All this support is received by his institution (CHUV) and is used for stroke education and research.

Supplementary material

10286_2018_544_MOESM1_ESM.docx (25 kb)
Supplementary material 1 (DOCX 24 kb)

References

  1. 1.
    Wallenberg A (1895) Acute bulbar affection. Arch Psychiatr Nervenheilkd 27:504–540CrossRefGoogle Scholar
  2. 2.
    Schievink WI (2001) Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 344:898–906CrossRefPubMedGoogle Scholar
  3. 3.
    Rossetti AO, Reichhart MD, Bogousslavsky J (2003) Central Horner’s syndrome with contralateral ataxic hemiparesis: a diencephalic alternate syndrome. Neurology 61:334–338CrossRefPubMedGoogle Scholar
  4. 4.
    Schiffter R, Reinhart K (1980) The telodiencephalic ischemic syndrome. J Neurol 222:265–274CrossRefPubMedGoogle Scholar
  5. 5.
    Michel P, Odier C, Rutgers M et al (2010) The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke 41:2491–2498CrossRefPubMedGoogle Scholar
  6. 6.
    Wintermark M, Flanders AE, Velthuis B et al (2006) Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 37(4):979–985CrossRefPubMedGoogle Scholar
  7. 7.
    Stone WM, de Toledo J, Romanul FC (1986) Horner’s syndrome due to hypothalamic infarction. Clinical, radiologic, and pathologic correlations. Arch Neurol 43:199–200CrossRefPubMedGoogle Scholar
  8. 8.
    Nagy AN, Hayman LA, Diaz-Marchan PJ, Lee AG (1997) Hornerʼs syndrome due to first-order neuron lesions of the oculosympathetic pathway. AJR Am J Roentgenol 169:581–584CrossRefPubMedGoogle Scholar
  9. 9.
    Austin CP, Lessell S (1991) Hornerʼs syndrome from hypothalamic infarction. Arch Neurol 48:332–334CrossRefPubMedGoogle Scholar
  10. 10.
    Maloney WF, Younge BR, Moyer NJ (1980) Evaluation of the causes and accuracy of pharmacologic localization in Horner’s syndrome. Am J Ophthalmol 90:394–402CrossRefPubMedGoogle Scholar
  11. 11.
    Kardon R (2005) Walsh and Hoyt clinical neuro-ophthalmology. In: Miller NR, Newman NJ (eds) Anatomy and physiology of the autonomic nervous system, vol 6. Williams & Wilkins, Baltimore, pp 649–712Google Scholar
  12. 12.
    Amonoo-Kuofi HS (1999) Hornerʼs syndrome revisited: with an update of the central pathway. Clin Anat 12:345–361CrossRefPubMedGoogle Scholar
  13. 13.
    Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC (1992) Cardiovascular effects of human insular cortex stimulation. Neurology 42:1727–1732CrossRefPubMedGoogle Scholar
  14. 14.
    Faust-Socher A, Greenberg G, Inzelberg R (2013) Thalamic-hypothalamic infarction presenting as first-order Horner syndrome. J Neurol 260:1673–1674CrossRefPubMedGoogle Scholar
  15. 15.
    Provenzale JM, Sarikaya B (2009) Comparison of test performance characteristics of MRI, MR angiography, and CT angiography in the diagnosis of carotid and vertebral artery dissection: a review of the medical literature. AJR Am J Roentgenol 193(4):1167–1174CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Stroke Center and Neurology Service, Department of Clinical NeurosciencesCentre Hospitalier Universitaire Vaudois and University of LausanneLausanneSwitzerland
  2. 2.Service of Diagnostic and Interventional RadiologyCentre Hospitalier Universitaire Vaudois and University of LausanneLausanneSwitzerland
  3. 3.Neurology ServiceCentre Hospitalier Universitaire Vaudois and University of LausanneLausanneSwitzerland

Personalised recommendations